{"_id":"qn37nCmnQBXpvy69EXNTyhIyfQLcj9yYRxZGEBaKyPKueHT9aUIx2q","lastupdate":"2024-10-28T00:00:00.000Z","update_date":"2024-10-28T00:00:00.000Z","lastModified":"Jun 25, 2025","active":1,"confidence_score":89,"confidence_score_reason":"video or image, markets, not claimed","urlname":"remepy","minimal_profile":null,"status":"","fullstatus":"","acquired":0,"hide_reason":null,"hide_reason_data":null,"hide_reasons":[{"id":"8257rxn4P8EFQOmS5hAAauHyYMhhxrA5u6yWX4XUShpybX3AMNo3Y9","reason":"Pending approval - External entity"},{"id":"aOIaOiiqfpA8UMw6VCTh8ueRmkG3lzDy1NGqEOaJbe11OrCzMTCCd6","reason":"The company is a service provider"},{"id":"ddgjKuc3GgH8E5UehSVJviRl471BCajL1plO8HtGoOojy2NivYqQ7x","reason":"Owner asked to delete"},{"id":"EjOKM211H1ira9J63oaGPuUxvr7Oba55TZo3NWsFO5uhbNu7o4x4zD","reason":"The company is not Israeli"},{"id":"J7fQJtnT3GdWWSE3MD8rzaW65LJ4jEIKxSZnneQiReONdZjG3zIqWe","reason":"Owner asked to hide in the meantime"},{"id":"NxlAC3ReFb5ksiYNLp2FnUyluoJzwRCYfcF7xpTZaPM53SdWQ5kv0B","reason":"Pending approval"},{"id":"RhC1tlwXzioK0MfzBII3H2wepEfQOfKVktmdwqeqTJjGi3ZaBWUqZo","reason":"The company is not innovative"},{"id":"S0Ed46vNI6vZYVxLedANWGjas23K6hY0QdsCtiGYL7lshqIEdLV3sA","reason":"The company ceased operations in Israel"},{"id":"VTANq7bEvlsEcPjp0ghelXfShaCosgndONGjgU730aAOxXtaDIF5j3","reason":"This is a product of an existing company"}],"type":"Startup","logokey":"$2XgkKrx8pNK2giVWlcjN9I5cD44mr0FYeASz90u93gIhJ3ZzXJz7Wp.jpeg","name":"Remepy","oneliner":"Pioneering Hybrid Drugs","registrar":"516671476","website":"https://www.remepy.com/","careerspage":"https://www.remepy.com/careers","founded_month":12,"founded_year":2021,"formernames":[],"sociallinks":{"twitter":"","youtube":"","facebook":"","linkedin":"https://www.linkedin.com/company/82435157","instagram":""},"social":["https://www.linkedin.com/company/82435157"],"flattenedsociallinks":"https://www.linkedin.com/company/82435157","apps":{"appstore":"","googleplay":""},"is_claimed_by_owner":1,"employees":"51-200","employees_exact":59,"patent":1,"raised":25000000,"stage":"Seed","public_stage":"Seed","primary_sector_key":"agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","primary_sector":"Health Tech & Life Sciences","alternativenames":null,"about":"Remepy is pioneering hybrid drugs, and redefining combination therapy. Its mission is to bring better personalized care to patients.\n\nRemepy’s Digital molecules are mobile applications designed for hybrid drug experiences, each containing a unique digital treatment protocol. Its Digital molecules include digitized, standardized, evidence-based interventions, designed to enhance brain plasticity and connectivity, balance the immune system, and drive behavioral changes. The company addresses disease end-points as well as side-effects and disease comorbidities.\n\nRemepy partners with pharma companies to bring Hybrid Drugs to market that will combine Remepy’s Digital Molecule and traditional drug components.","climatetech_description":null,"is_climatetech_relevant":null,"phone":null,"country":null,"address":{"israeli":[{"id":"6WoCje4x9UTm3ckac8wBqtdLisEp6Ukcb42PYqkMivwNZPzsabdqsd","city":"Ramat Gan","type":null,"address":"Ramat Gan, Israel","placeid":"ChIJreSU54ZMHRURb1IX5z6_AC0","notactive":null,"openeddate":null,"registrarid":null,"firstrdcenter":null,"registrarname":null}],"officesabroad":null},"headquarter_address":null,"district":"Center District","news":[{"id":"zYdfxV6a6RIQ8ZdAt83wn83rVqllIcuPfkzSCDt5XxkTMPqkKWFq5W","date":"Jun 22, 2025","link":"https://insights.citeline.com/medtech-insight/device-area/neurology/remepy-to-embed-ai-in-next-gen-digital-therapeutics-for-personalized-neuroimmune-modulation-UKR75QBUORHNXD3AET6QASGGZQ/","source":"insights.citeline.com","visible":1,"analysis":{"tags":"regulatory strategy","round":null,"company":"Remepy","layoffs":null,"summary":"Remepy is advancing its RMPY-008 app by incorporating adaptive sequencing, journaling tools, and phenotyping capabilities. The company is exploring two regulatory pathways to integrate software and drug into a single therapeutic entity. The first pathway involves a combination product approach, while the second utilizes the FDA’s Prescription Drug Use-Related Software (PDURS) pathway. The RMPY-008 app delivers its protocol through cognitive-emotional tasks and sensory modulation, aiming to enhance therapeutic outcomes.","partners":null,"customers":null,"eventType":null,"investors":null,"confidence":9,"key_topics":["adaptive sequencing","journaling tools","phenotyping","regulatory pathways","software integration"],"date_of_event":"23 Jun 2025","product_stage":"R&D","investment_date":null,"acquired_company":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":[],"acquisition_amount":null,"FDA approved/pending approval":"pending approval","AI technology developing/using":"developing","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"jyAjYG4gjjRuEFAGnMHc7YKWs4elE3zAjc6yXSLxnp7tJoUawA1mjO","news_summary":"Remepy To Embed AI In Next-Gen Digital Therapeutics For Personalized Neuroimmune Modulation","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"A6xi50U6zQII3D90idYTV6m2CEBIjJXkASfpfgDgMeCgZRQYUWM8Ya","date":"Jun 17, 2025","link":"https://www.morningstar.com/news/pr-newswire/20250618ln12531/remepys-mobile-app-shown-to-rewire-brain-modulate-immune-system-and-improve-mood-in-adults-with-subjective-cognitive-decline","source":"www.morningstar.com","visible":1,"analysis":{"tags":"digital intervention","round":null,"company":"Remepy","layoffs":null,"summary":"Remepy, a pioneer in hybrid drugs integrating digital and pharmacological interventions, announced that its app-based intervention, RMPY-008, demonstrated significant modulation of inflammatory blood biomarkers in a clinical trial. The study, involving 103 adults, showed that the digital intervention reduced depressive symptoms and improved brain connectivity in individuals with subjective cognitive decline. The findings suggest that RMPY-008 can modulate both brain and immune functions, offering a new therapeutic modality. The app achieved high adherence and engagement, with participants showing sustained benefits. Remepy is commercializing its platform in collaboration with pharmaceutical partners, focusing initially on Parkinsons disease, with plans to expand into fertility, oncology, and immunology.","partners":"pharma partners","customers":null,"eventType":null,"investors":null,"confidence":9,"key_topics":["inflammation","cognitive decline","brain connectivity","immune modulation","digital intervention"],"date_of_event":"2025","product_stage":"clinical trial","investment_date":null,"acquired_company":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Product Stage","Partners"],"acquisition_amount":null,"FDA approved/pending approval":"pending approval","AI technology developing/using":"developing","structuredIssuesShow":"#Product Stage  #Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"kMTbc9SANdLR5kIYUlAgdztGhBGXZ2mxLR6n9zhzr8rUwnXQHnReKo","news_summary":"Remepy's Mobile App Shown to Rewire Brain, Modulate Immune System and Improve Mood in Adults with Subjective Cognitive Decline","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"LQWnA68Jec3nCVLyjziOeBSl9nBMVfwnqOYvbBEl4PIeDhm5pIXyq7","date":"Dec 9, 2024","link":"https://en.globes.co.il/en/article-the-best-parkinsons-medication-will-be-israeli-and-hybrid-1001496309","source":"en.globes.co.il","visible":1,"analysis":{"tags":"innovation","company":"Remepy","layoffs":null,"summary":"Remepy, a company co-founded by Dr. Michal Tsur, is pioneering the development of hybrid medications, combining digital applications with traditional drugs. At the 2024 Globes Israel Business Conference, Tsur highlighted the potential of these medications, particularly for Parkinsons disease, following a successful clinical trial. The company aims to revolutionize the pharmaceutical industry by integrating digital treatment protocols with chemical elements, enhancing treatment accessibility and effectiveness. Additionally, Tsur is exploring the establishment of a new airline to offer affordable flights, addressing the current scarcity and high cost of air travel to and from Israel. This initiative reflects the broader trend of high-tech entrepreneurship addressing public sector gaps. Tsur emphasizes the importance of private sector innovation in improving public life, advocating for proactive solutions to societal challenges.","partners":null,"customers":null,"investors":null,"confidence":9,"key_topics":["hybrid medication","Parkinsons treatment","entrepreneurship","aviation","digital health"],"date_of_event":"December 9, 2024","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":[],"acquisition_amount":null,"entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"CQhDI0fgYF8SuBJwCIbXyumKcszxrBr3qa3q6pBRFbGk1Eo5OAwOIm","news_summary":"Remepy co-founder Michal Tsur told the Israel Business Conference about the therapy revolution whose time has come.","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"SKkABjKSD9MVFIjli1dwVXOS58bVkgxjedQ96bydvP7EeqmQoNZoBy","date":"Jun 5, 2024","link":"https://www.forbes.com/sites/gilpress/2024/06/06/israeli-startup-combines-software-with-medicine-to-transform-16-trillion-pharma-market/","source":"www.forbes.com","visible":1,"analysis":{"tags":"hybrid drugs","round":"seed","company":"Remepy","layoffs":null,"summary":"Remepy, an Israeli startup, is pioneering the development of hybrid drugs by combining software with traditional medicine. The company has successfully closed a $10 million seed investment round, bringing its total funding to $15 million. The investment was led by NFX and included several other venture firms. Remepy aims to standardize and personalize therapeutic interventions using digital molecules, which have shown promising results in early clinical studies. The company plans to target diseases like Parkinson’s, neurodegenerative diseases, and cancer. Remepy has also announced new board members, including Danny Bar Zohar from Merck and former Israeli Prime Minister Naftali Bennett. The companys approach could potentially halve the time required to bring new drugs to market.","partners":null,"customers":null,"eventType":null,"investors":["NFX","Vine Ventures","PsyMed Ventures","Supernode Ventures","Firstime Ventures","TechAviv","Fresh.fund","Samsung Next","StageNext Fund","97212 Ventures"],"confidence":9,"key_topics":["hybrid drugs","digital molecules","investment","clinical studies","board changes"],"date_of_event":"last month","product_stage":"early clinical studies","investment_date":"last month","acquired_company":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"$10 million","structured_issues":["Investment","Management Changes","Product Stage"],"acquisition_amount":null,"FDA approved/pending approval":"pending approval","AI technology developing/using":"developing","structuredIssuesShow":"#Investment  #Management Changes  #Product Stage","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"cztygD7gDoBh1oSOkKcCAczpSvT4WpBHX0GsxoZYOfYpnnMEW7ZfVc","news_summary":"Israeli Startup Combines Software With Medicine To Transform Pharma","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"wVE9irs3BKd9JKqUKPO4LE0ZCfqhxl0xK3EA4jJiS3Y5urLLRnNWsY","date":"May 1, 2024","link":"https://www.calcalistech.com/ctechnews/article/sytmfh1m0","source":"www.calcalistech.com","visible":1,"analysis":{"tags":"Investment, Hybrid Drugs, Digital Molecules","company":"Remepy","layoffs":"Not Mentioned","summary":"Israeli startup Remepy has raised $10 million in a seed investment round, bringing its total funding to $15 million. The round was led by NFX and included participation from Vine Ventures, Psymed Ventures, Supernode Ventures, and Firstime Ventures, among others. Remepy is developing hybrid drugs that combine traditional drugs with its digital molecules, therapeutic interventions that trigger physiological effects through the brain. The company has shown promising results in human studies for Oncology, MCI, and Parkinson’s Disease. Dr. Danny Bar Zohar, Merck’s Global head of R&D and Chief Medical Officer, will be joining the board.","partners":"Not Mentioned","customers":"Not Mentioned","investors":["NFX","Vine Ventures","Psymed Ventures","Supernode Ventures","Firstime Ventures","TechAviv","fresh.fund","97212 Ventures"],"confidence":9,"key_topics":["Investment Round","Hybrid Drugs","Digital Molecules","Board Addition","Parkinsons Disease Treatment"],"date_of_event":"Not Mentioned","valuation_amount":"Not Mentioned","impact_on_company":"growth-positive","investment_amount":"$10 million","structured_issues":["Investment","Management Changes"],"acquisition_amount":"Not Mentioned","structuredIssuesShow":"#Investment  #Management Changes","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"YKnDNKh8CUjkunQQQvosdzVPVi3pYuihl1hFD5Vwi528hO1bmd5H0g","news_summary":"Remepy raises $10 million Seed round to bring first hybrid drug to market | CTech","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"DGSLEkTgr04mOsvqQ74o4gWmbAK4AUuWXwEuFYNF0VVbUhWQvQXH0z","date":"Feb 13, 2024","link":"https://www.calcalistech.com/ctechnews/article/h1eacxqoa","source":"www.calcalistech.com","visible":1,"analysis":{"tags":"Board Appointment, Hybrid Drugs","company":"Remepy","layoffs":"N/A","summary":"Former Prime Minister of Israel, Naftali Bennett, has joined the board of Remepy, a company co-founded by Dr. Michal Tsur, his former co-founder from Cyota. This is the third high-tech board Bennett has joined since he left politics, previously joining AI cyber company Lasoo and quantum computing startup Quantum Source. Remepy is developing hybrid drugs that include therapeutic applications to enhance the drug effect. The company has demonstrated the physiological effect of its digital interventions in early clinical studies.","partners":"N/A","customers":"N/A","investors":"N/A","confidence":9,"key_topics":["Hybrid Drugs","Board Appointment","Naftali Bennett","Michal Tsur","Cyota"],"date_of_event":"N/A","valuation_amount":"N/A","impact_on_company":"growth-positive","investment_amount":"N/A","structured_issues":["Management Changes"],"acquisition_amount":"N/A","structuredIssuesShow":"#Management Changes","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"yI8aLx1B0xIHy1x1ij20ecJNxvkFJsMXkdfyJ4c3t3L1N6R9GEvbjQ","news_summary":"Naftali Bennett and Michal Tsur unite at Remepy: Former PM joins Board for hybrid drug endeavor | CTech","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"FKqfby7ykuxZ9bKJ0SKTteHGW55bIJg39PLkyQnvyj5OPL90ntWZhq","date":"Feb 7, 2023","link":"https://shalem.ac.il/en/news/drugs-in-a-digital-world-shalem-grad-or-shoval-22-launches-innovative-digital-health-company/","source":"shalem.ac.il","visible":1,"analysis":{"tags":"healthcare, pharmaceuticals","company":"Remepy","layoffs":null,"summary":"Remepy, an innovative health platform, aims to optimize drugs impact and save more lives by integrating mind and body through cognitive-behavioral exercises and other practices drawn from neuroscience. The company has raised over $2.5M in seed funding and is in negotiations with several Israeli and global pharmaceutical companies and hospitals. Remepys co-founder, Or Shoval, credits his education at Shalem for providing him with the skills and confidence to approach unfamiliar subjects and lead the market validation process. The company is now seeking tier-1 data validation through clinical trials and plans to expand its team of experts.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["Remepy","health platform","pharmaceutical industry","digital therapeutics","clinical trials"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"$2.5M","structured_issues":["Investment","Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Investment  #Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"KmZNxeDe8PkJht16HbrAJBnMmCPvcpOEHg4FLP2zqN7j8ruGF003YD","news_summary":"Drugs in a Digital World: Shalem Grad Or Shoval '22 Launches Innovative Digital-Health Company - Shalem College","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"}],"newsNumber":7,"techcommunityinvolvement":null,"mediagallery":[],"tags":["digital-healthcare","saas","drug-discovery","drug-development","pharmaceuticals"],"classificationIDs":["agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety7cLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1i8MIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NuxioUJDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA"],"technologysuccessstory":null,"usecases":[],"businessmodels":["B2B","B2B2C"],"productstage":"Clinical Trial","products":[],"geomarkets":["United States"],"targetmarkets":[],"marketcapital":null,"marketcapitaldate":null,"funding":{"investors":9,"lastfunding":"$10M","totalrounds":3,"fundingstage":"Seed","totalfunding":"$25M","publicinvestors":9,"lastpublicfunding":10000000,"totalpublicrounds":3,"totalpublicfunding":25000000},"team":[{"name":"Or Shoval","email":"or@remepy.com","phone":"","gender":"Male","userid":"aEPJMPQos1wMx56ORLIe0EsayDNkSmtKlErVf41GQM2WfkmejhZ2xB","bounced":false,"claimed":1,"founder":1,"urlname":"or-shoval-1","visible":1,"memberid":"LLRITnU4RGiKnWT6tMUBinI63tUoPujNbVNgQYXdaHa9svGqJgn9n1","position":"Co-founder & CEO","last_name":"Shoval","claimtoken":"ggAQZH2l9Y4ZKuesZTp7rCiTJ0RIELH4qCAa8Fcywe2RaPSJBBft0K","first_name":"Or","picturekey":null,"claimeddate":"2023-02-05","linkedinurl":"https://www.linkedin.com/in/or-shoval/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2022-08-31 09:03:01.000000","initials":"OS","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Michal Tsur","email":"michal@remepy.com","phone":"+16462905445","gender":"Female","userid":"imTUaeiQc3Ab2hWTCTMRnLIZd7r9R2b3EAwuyl5xgcfndvZV74MBEV","bounced":false,"claimed":null,"founder":1,"urlname":"michal-tsur-1","visible":1,"memberid":"oNM1zcGi9s6ksZkXmiV18Fjl5lgxX7CyEBmO6PMLPJh8tXwTPUCTP4","position":"Co-founder & CEO","last_name":"Tsur","claimtoken":"pjAVzDLaM8UW6YcHkqM9ls1heF5iLU6tPZmRyWYJ36l2BhpWnCNLm5","first_name":"Michal","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/michaltsur/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2025-01-28 18:35:05.000000","initials":"MT","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Shahar Shelly","email":"shahar@remepy.com","phone":"","gender":"Male","userid":"IEjPI0zFPNxPqntZSnBuCRY9sH2dnBc1NJzWXVrX5k6XVJ2s407zSk","bounced":false,"claimed":null,"founder":1,"urlname":"shahar-shelly","visible":1,"memberid":"HhTy1IuyE40kKkILZauvGtl09LzbxDCbN9iDQiXIyFSyE5t4JJXOiB","position":"Co-founder & CMO","last_name":"Shelly","claimtoken":"uS0BO18NLPl8pZNVzhHPiI7huMpnZMnAs2fdlpeuquW6N4ySsnvTsG","first_name":"Shahar","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/shahar-shelly-m-d-28153899/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2024-10-28 12:45:35.000000","initials":"SS","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Or Shoval","email":"orshoval9@gmail.com","phone":"","gender":null,"userid":"aEPJMPQos1wMx56ORLIe0EsayDNkSmtKlErVf41GQM2WfkmejhZ2xB","bounced":false,"claimed":1,"founder":null,"urlname":"or-shoval-1","visible":1,"memberid":"SDFaFdxIdCyV0HSGCLWSGqYxIX7H5AFMjkqZJHS8CO0JBbvJsBNPvb","position":"","last_name":"Shoval","claimtoken":null,"first_name":"Or","picturekey":"$PIQ2TTGHReyZNx0OAvIeZJOrZkQv4VDs01r3nKe4udnunWtzhDrk89","claimeddate":"2025-06-25","linkedinurl":null,"unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":null,"initials":"","pictureurl":"https://storage.googleapis.com/clean-finder-353810/$PIQ2TTGHReyZNx0OAvIeZJOrZkQv4VDs01r3nKe4udnunWtzhDrk89","linkedin-display":"none","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""}],"description_edited":null,"tag_line_edited":null,"sector":"Digital Health and Medical Technologies","sectorverify":null,"biverify":{"id":"c9EsgAuuvwml0IzyIKWmOxLUUF5GjptiIXjHR1tp2gTB0O2GoGTfCd","fullname":"Yanina Wainscheinker"},"biverifydate":"2024-10-28T00:00:00.000Z","crunchbaseid":null,"lastupdator":"Yanina Wainscheinker","lastupdator_email":"yanina.wainscheinker@sncentral.org","creator":"Jenny Sotnik-Talisman","creator_email":"jenny.sotnik@sncentral.org","createdate":"2022-08-31T00:00:00.000Z","biverification":"Yanina Wainscheinker","sectorverification":null,"affiliatedOrganizations":null,"timeline":[{"id":"CBl7GnN7sIYIa9IkTz94dad9FpgVOAu22tJusU3qhZY6X1eTKEbP75","date":"Mar 2025","amount":"$10M","source":"","eventtype":"FundingRoundEvent","investment":[],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Seed","style":"","hiddenCompanyTooltip":"","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","sectionname":"Private Equity Funding","amountnumber":10000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"SnzeaOxsxXF7JGlUuOiMTtYdbjgF8akEFHqqldWTasSTDZ4AS1qZ48","date":"May 2024","amount":"$10M","source":"https://www.calcalistech.com/ctechnews/article/sytmfh1m0","eventtype":"FundingRoundEvent","investment":[{"name":"NFX Capital","type":"Investor","amount":null,"hidden":false,"country":"United States","fullurl":"/investor_page/nfx-guild1","logokey":"$wyFW415Hl7g4xa3CX4uzm5VjA6wcovghFNMwaB46FtfD9vlqyR2iuC","tagline":null,"urlname":"/investor_page/nfx-guild1","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4KTEh9IIDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"aL7ILnT9quOFWWEnNUzgLQn5RWq3qlnLQLgC3sQ3GahXe0aTK8MgQW","fundingsubtype":"VC and Private Equity","investorislead":1,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$wyFW415Hl7g4xa3CX4uzm5VjA6wcovghFNMwaB46FtfD9vlqyR2iuC","leadcaption":"Lead ","followupcaption":""},{"name":"Vine Ventures","type":"Investor","amount":null,"hidden":false,"country":"United States","fullurl":"/investor_page/vine","logokey":"$Ztun4W2jVv8Wv1WlGKfQw7ZoaYJInCuQJ5sIFV2BKaBscb2PWIVMW7","tagline":null,"urlname":"/investor_page/vine","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAkOKx26oKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"CK9qI26sQek5DsJZjxE8HeqxsQNaGZcpxetXokmQRgt9ymU7M13BMM","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$Ztun4W2jVv8Wv1WlGKfQw7ZoaYJInCuQJ5sIFV2BKaBscb2PWIVMW7","leadcaption":"","followupcaption":""},{"name":"Psymed Ventures","type":"Investor","amount":null,"hidden":false,"country":"United States","fullurl":"/investor_page/psymed-ventures","logokey":"$I8MjW1Gpl3JR0jWUUB71vIfXKkjFhpCdfc9AydOKJX904I6Gr0AGm4.jpeg","tagline":null,"urlname":"/investor_page/psymed-ventures","isisraeli":0,"investorid":"y9fpL1eaIAjb16FMba0cPHVXwxsKZsbh4YGJRlZ7geIUs8TFx3V0R4","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"IWKkntDxopxbZ898PgsbMLARh9fOMCGunyRaZZLutNEBgRp1Pr5yYP","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$I8MjW1Gpl3JR0jWUUB71vIfXKkjFhpCdfc9AydOKJX904I6Gr0AGm4.jpeg","leadcaption":"","followupcaption":""},{"name":"TechAviv Founder Partners","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/techaviv-founder-partners","logokey":"$Mx6QVN5G8Qj70kWIa3WEK9vVM9NyI81zfXemCnDtIIr1b0qcKyWCfk.png","tagline":null,"urlname":"/investor_page/techaviv-founder-partners","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4Ivz1LULDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"L5VbqEcgw82Fv4zq4jrSsXO4LlB9BRhEgV1k1rdrrImjiK67IpDpNg","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$Mx6QVN5G8Qj70kWIa3WEK9vVM9NyI81zfXemCnDtIIr1b0qcKyWCfk.png","leadcaption":"","followupcaption":"Follow on "},{"name":"Supernode Ventures","type":"Investor","amount":null,"hidden":false,"country":"United States","fullurl":"/investor_page/supernode-ventures","logokey":"$TikyZFaSEWjssSKz3G9FgHUUujIuKMv94GuoAOFL63FEqEmAJkA97b","tagline":"Venture capital firm","urlname":"/investor_page/supernode-ventures","isisraeli":0,"investorid":"wxU2CcA7ODmhVs3mzuGgHbJEkouFAal8yYJQU8oGr8MwWLxj4x1uZx","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"Qaxo1gS07a0FTLUWhLcezoSFNyNbOdkfBm6vr5bdFEMw5JZDHHofs0","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$TikyZFaSEWjssSKz3G9FgHUUujIuKMv94GuoAOFL63FEqEmAJkA97b","leadcaption":"","followupcaption":"Follow on "},{"name":"Firstime VC","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/firstime","logokey":"$cTJW8FRLbAFqwvIDxKq2ID6fHXBWhB1HoMjPJWe3geb2uo1phYRY4G","tagline":null,"urlname":"/investor_page/firstime","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgNHK1IUKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"fc5sIaFJdYW5K2ktd48mm00flo9ek1BjqIMoBxqZoz1V22KfQVQ6QT","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$cTJW8FRLbAFqwvIDxKq2ID6fHXBWhB1HoMjPJWe3geb2uo1phYRY4G","leadcaption":"","followupcaption":""},{"name":"97212 Ventures","type":"Investor","amount":null,"hidden":false,"country":"United States","fullurl":"/investor_page/97212-ventures","logokey":"$2apjhfXlApSz60TUUkmzaHq46sbv24idAgYo1PikUoIu0h2wGBlDfE","tagline":"","urlname":"/investor_page/97212-ventures","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgJDs-pC4CAw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"tzOJur8nIZ1w6XlUzYrEVIDNyYUNuTktPK0cAQWerg3WzAwNNV9TNL","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$2apjhfXlApSz60TUUkmzaHq46sbv24idAgYo1PikUoIu0h2wGBlDfE","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Seed","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":10000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"VpoKWwQG0tTqa2lUMZZRTpXKEnZCBdKbmRoIP1Btmt6YeGVGgrhtLO","date":"Dec 2022","amount":"$5M","source":"https://www.calcalistech.com/ctechnews/article/sytmfh1m0","eventtype":"FundingRoundEvent","investment":[{"name":"Fresh Fund","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/fresh-fund","logokey":"$BHriUC9fG6Z2h8SJ15VxXlmD1SY4fuXnbS8n6Z6MfxFWjunbLVRsvL.jpeg","tagline":null,"urlname":"/investor_page/fresh-fund","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwJGvzoEJDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"NQnQiE0qHPvVaLnZSf4oNjDoDxJa7UrDhvd2TURPWMQTHVgaECMFbK","fundingsubtype":"VC and Private Equity","investorislead":1,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":null,"leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$BHriUC9fG6Z2h8SJ15VxXlmD1SY4fuXnbS8n6Z6MfxFWjunbLVRsvL.jpeg","leadcaption":"Lead ","followupcaption":""},{"name":"TechAviv Founder Partners","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/techaviv-founder-partners","logokey":"$Mx6QVN5G8Qj70kWIa3WEK9vVM9NyI81zfXemCnDtIIr1b0qcKyWCfk.png","tagline":null,"urlname":"/investor_page/techaviv-founder-partners","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4Ivz1LULDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"6IyZv5s1y04dm9aDJITFZAXTHxWS0nQhrNohJf0xHW5ymoKu84m3zY","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$Mx6QVN5G8Qj70kWIa3WEK9vVM9NyI81zfXemCnDtIIr1b0qcKyWCfk.png","leadcaption":"","followupcaption":""},{"name":"Samsung Next TLV","type":"Investor","amount":null,"hidden":false,"country":"United States","fullurl":"/investor_page/samsung-next-tlv","logokey":"$oPD5FTb5fGsUqtq4RH2XKfkNNIWs4LZyPZQsOaIF77uo9mM07tylAX","tagline":null,"urlname":"/investor_page/samsung-next-tlv","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwOPhwoYLDA","fundingtype":"Corporate VC","leadpartner":null,"investmentid":"VIGSO7igNTxhC5wWS3SQgcF5yJG8vhVVOBZUUIhMJ3yGIrM00mPtMP","fundingsubtype":"Corporate VC","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$oPD5FTb5fGsUqtq4RH2XKfkNNIWs4LZyPZQsOaIF77uo9mM07tylAX","leadcaption":"","followupcaption":""},{"name":"Supernode Ventures","type":"Investor","amount":null,"hidden":false,"country":"United States","fullurl":"/investor_page/supernode-ventures","logokey":"$TikyZFaSEWjssSKz3G9FgHUUujIuKMv94GuoAOFL63FEqEmAJkA97b","tagline":"Venture capital firm","urlname":"/investor_page/supernode-ventures","isisraeli":0,"investorid":"wxU2CcA7ODmhVs3mzuGgHbJEkouFAal8yYJQU8oGr8MwWLxj4x1uZx","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"hZOoNlEIdFC0V5IBHr7cwUiEJdP07ZxqBuqpHZGqoJFY6DChqZOHX3","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$TikyZFaSEWjssSKz3G9FgHUUujIuKMv94GuoAOFL63FEqEmAJkA97b","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Seed","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":5000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"investmentstage":[],"exits":[],"investments":[],"portfolio":[],"funds":[],"founded":"12/2021","databases":[],"sharedspaces":[],"utilities":[],"contributors":[],"employeesworldwide":"","fundingtype":"Startup","parsedName":"Remepy","logourl":"https://storage.googleapis.com/clean-finder-353810/$2XgkKrx8pNK2giVWlcjN9I5cD44mr0FYeASz90u93gIhJ3ZzXJz7Wp.jpeg","oglogourl":"https://storage.googleapis.com/clean-finder-353810/$2XgkKrx8pNK2giVWlcjN9I5cD44mr0FYeASz90u93gIhJ3ZzXJz7Wp.jpeg","seoabout":"Remepy is pioneering hybrid drugs, and redefining combination therapy. Its mission is to bring better personalized care to patients.\n\nRemepy’s Digital mole...","seoTitle":"Israeli Startup","solutions":[],"teamMembersNumber":4,"primarySector":"Health Tech & Life Sciences","primary-sector-display":"block","classifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Digital Healthcare","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA","classificationName":"sectorclassification"},{"depth":3,"name":"Medical Decision Support","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety7cLDA","classificationName":"sectorclassification"},{"depth":2,"name":"Pharma & Medical Biotechnology","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","classificationName":"sectorclassification"},{"depth":3,"name":"Drugs Discovery & Development","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA","classificationName":"sectorclassification"},{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Platforms & Interfaces","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NuxioUJDA","classificationName":"coretechnology"},{"depth":2,"name":"Software","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1i8MIDA","classificationName":"coretechnology"},{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","classificationName":"targetcustomer"},{"depth":3,"name":"Pharmaceuticals","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","classificationName":"targetcustomer"}],"classificationDelimited":["SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Digital Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA>Medical Decision Support#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety7cLDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Digital Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA>Drugs Discovery & Development#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA","TechnologyClassificationModel>Platforms & Interfaces#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NuxioUJDA>Software#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1i8MIDA","TechnologyClassificationModel>Platforms & Interfaces#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NuxioUJDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA>Pharmaceuticals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA"],"classificationsViewModel":"|0:>SectorClassificationModel|1:>SectorClassificationModel/Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA|2:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA/Digital Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA|3:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Digital Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA/Medical Decision Support#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety7cLDA|2:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA/Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA|3:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA/Drugs Discovery & Development#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA|0:>IndustryClassificationModel|1:>IndustryClassificationModel/Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA|2:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA/Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA/Pharmaceuticals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA|0:>TechnologyClassificationModel|1:>TechnologyClassificationModel/Platforms & Interfaces#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NuxioUJDA|2:>TechnologyClassificationModel>Platforms & Interfaces#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NuxioUJDA/Software#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1i8MIDA|","classificationTrees":{"sector":[{"title":"Health Tech & Life Sciences","key":"0-0","path":"SectorClassificationModel>Health Tech & Life Sciences","children":[{"title":"Digital Healthcare","key":"0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Digital Healthcare","children":[{"title":"Medical Decision Support","key":"0-0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Digital Healthcare>Medical Decision Support"}]},{"title":"Pharma & Medical Biotechnology","key":"0-0-1","path":"SectorClassificationModel>Health Tech & Life Sciences>Pharma & Medical Biotechnology","children":[{"title":"Drugs Discovery & Development","key":"0-0-1-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Pharma & Medical Biotechnology>Drugs Discovery & Development"}]}]}],"targetCustomer":[{"title":"Healthcare & Life Sciences","key":"0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences","children":[{"title":"Life Sciences","key":"0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Life Sciences","children":[{"title":"Pharmaceuticals","key":"0-0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Life Sciences>Pharmaceuticals"}]}]}],"coreTechnology":[{"title":"Platforms & Interfaces","key":"0-0","path":"TechnologyClassificationModel>Platforms & Interfaces","children":[{"title":"Software","key":"0-0-0","path":"TechnologyClassificationModel>Platforms & Interfaces>Software"}]}]},"sectorClassifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Digital Healthcare","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA","classificationName":"sectorclassification"},{"depth":3,"name":"Medical Decision Support","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety7cLDA","classificationName":"sectorclassification"},{"depth":2,"name":"Pharma & Medical Biotechnology","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","classificationName":"sectorclassification"},{"depth":3,"name":"Drugs Discovery & Development","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA","classificationName":"sectorclassification"}],"coreTechnologyClassifications":[{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Platforms & Interfaces","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NuxioUJDA","classificationName":"coretechnology"},{"depth":2,"name":"Software","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1i8MIDA","classificationName":"coretechnology"}],"targetCustomerClassifications":[{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","classificationName":"targetcustomer"},{"depth":3,"name":"Pharmaceuticals","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","classificationName":"targetcustomer"}],"classificationNames":{"sector":["Health Tech & Life Sciences","Digital Healthcare","Medical Decision Support","Pharma & Medical Biotechnology","Drugs Discovery & Development"],"coreTechnology":["Platforms & Interfaces","Software"],"targetCustomer":["Healthcare & Life Sciences","Life Sciences","Pharmaceuticals"]},"section":null,"sectionParams":"","queryParams":"","popup_claim_profile":"false","claimedBadge":"inline","display":{"mainContact":"none","climateTag":"none","seeMoreSimilarCompanisDisplay":"none","similarCompaniesTitleFontSize":"3.2rem","similarCompaniesTitle":"Similar Companies","similar_companies":[]},"mainContact":{},"_eventview":{"publicoffering_exit":[],"privateequityfunding":[{"id":"CBl7GnN7sIYIa9IkTz94dad9FpgVOAu22tJusU3qhZY6X1eTKEbP75","date":"Mar 2025","amount":"$10M","source":"","eventtype":"FundingRoundEvent","investment":[],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Seed","style":"","hiddenCompanyTooltip":"","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","sectionname":"Private Equity Funding","amountnumber":10000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"SnzeaOxsxXF7JGlUuOiMTtYdbjgF8akEFHqqldWTasSTDZ4AS1qZ48","date":"May 2024","amount":"$10M","source":"https://www.calcalistech.com/ctechnews/article/sytmfh1m0","eventtype":"FundingRoundEvent","investment":[{"name":"NFX Capital","type":"Investor","amount":null,"hidden":false,"country":"United States","fullurl":"/investor_page/nfx-guild1","logokey":"$wyFW415Hl7g4xa3CX4uzm5VjA6wcovghFNMwaB46FtfD9vlqyR2iuC","tagline":null,"urlname":"/investor_page/nfx-guild1","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4KTEh9IIDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"aL7ILnT9quOFWWEnNUzgLQn5RWq3qlnLQLgC3sQ3GahXe0aTK8MgQW","fundingsubtype":"VC and Private Equity","investorislead":1,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$wyFW415Hl7g4xa3CX4uzm5VjA6wcovghFNMwaB46FtfD9vlqyR2iuC","leadcaption":"Lead ","followupcaption":""},{"name":"Vine Ventures","type":"Investor","amount":null,"hidden":false,"country":"United States","fullurl":"/investor_page/vine","logokey":"$Ztun4W2jVv8Wv1WlGKfQw7ZoaYJInCuQJ5sIFV2BKaBscb2PWIVMW7","tagline":null,"urlname":"/investor_page/vine","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAkOKx26oKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"CK9qI26sQek5DsJZjxE8HeqxsQNaGZcpxetXokmQRgt9ymU7M13BMM","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$Ztun4W2jVv8Wv1WlGKfQw7ZoaYJInCuQJ5sIFV2BKaBscb2PWIVMW7","leadcaption":"","followupcaption":""},{"name":"Psymed Ventures","type":"Investor","amount":null,"hidden":false,"country":"United States","fullurl":"/investor_page/psymed-ventures","logokey":"$I8MjW1Gpl3JR0jWUUB71vIfXKkjFhpCdfc9AydOKJX904I6Gr0AGm4.jpeg","tagline":null,"urlname":"/investor_page/psymed-ventures","isisraeli":0,"investorid":"y9fpL1eaIAjb16FMba0cPHVXwxsKZsbh4YGJRlZ7geIUs8TFx3V0R4","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"IWKkntDxopxbZ898PgsbMLARh9fOMCGunyRaZZLutNEBgRp1Pr5yYP","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$I8MjW1Gpl3JR0jWUUB71vIfXKkjFhpCdfc9AydOKJX904I6Gr0AGm4.jpeg","leadcaption":"","followupcaption":""},{"name":"TechAviv Founder Partners","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/techaviv-founder-partners","logokey":"$Mx6QVN5G8Qj70kWIa3WEK9vVM9NyI81zfXemCnDtIIr1b0qcKyWCfk.png","tagline":null,"urlname":"/investor_page/techaviv-founder-partners","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4Ivz1LULDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"L5VbqEcgw82Fv4zq4jrSsXO4LlB9BRhEgV1k1rdrrImjiK67IpDpNg","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$Mx6QVN5G8Qj70kWIa3WEK9vVM9NyI81zfXemCnDtIIr1b0qcKyWCfk.png","leadcaption":"","followupcaption":"Follow on "},{"name":"Supernode Ventures","type":"Investor","amount":null,"hidden":false,"country":"United States","fullurl":"/investor_page/supernode-ventures","logokey":"$TikyZFaSEWjssSKz3G9FgHUUujIuKMv94GuoAOFL63FEqEmAJkA97b","tagline":"Venture capital firm","urlname":"/investor_page/supernode-ventures","isisraeli":0,"investorid":"wxU2CcA7ODmhVs3mzuGgHbJEkouFAal8yYJQU8oGr8MwWLxj4x1uZx","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"Qaxo1gS07a0FTLUWhLcezoSFNyNbOdkfBm6vr5bdFEMw5JZDHHofs0","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$TikyZFaSEWjssSKz3G9FgHUUujIuKMv94GuoAOFL63FEqEmAJkA97b","leadcaption":"","followupcaption":"Follow on "},{"name":"Firstime VC","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/firstime","logokey":"$cTJW8FRLbAFqwvIDxKq2ID6fHXBWhB1HoMjPJWe3geb2uo1phYRY4G","tagline":null,"urlname":"/investor_page/firstime","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgNHK1IUKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"fc5sIaFJdYW5K2ktd48mm00flo9ek1BjqIMoBxqZoz1V22KfQVQ6QT","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$cTJW8FRLbAFqwvIDxKq2ID6fHXBWhB1HoMjPJWe3geb2uo1phYRY4G","leadcaption":"","followupcaption":""},{"name":"97212 Ventures","type":"Investor","amount":null,"hidden":false,"country":"United States","fullurl":"/investor_page/97212-ventures","logokey":"$2apjhfXlApSz60TUUkmzaHq46sbv24idAgYo1PikUoIu0h2wGBlDfE","tagline":"","urlname":"/investor_page/97212-ventures","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgJDs-pC4CAw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"tzOJur8nIZ1w6XlUzYrEVIDNyYUNuTktPK0cAQWerg3WzAwNNV9TNL","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$2apjhfXlApSz60TUUkmzaHq46sbv24idAgYo1PikUoIu0h2wGBlDfE","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Seed","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":10000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"VpoKWwQG0tTqa2lUMZZRTpXKEnZCBdKbmRoIP1Btmt6YeGVGgrhtLO","date":"Dec 2022","amount":"$5M","source":"https://www.calcalistech.com/ctechnews/article/sytmfh1m0","eventtype":"FundingRoundEvent","investment":[{"name":"Fresh Fund","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/fresh-fund","logokey":"$BHriUC9fG6Z2h8SJ15VxXlmD1SY4fuXnbS8n6Z6MfxFWjunbLVRsvL.jpeg","tagline":null,"urlname":"/investor_page/fresh-fund","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwJGvzoEJDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"NQnQiE0qHPvVaLnZSf4oNjDoDxJa7UrDhvd2TURPWMQTHVgaECMFbK","fundingsubtype":"VC and Private Equity","investorislead":1,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":null,"leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$BHriUC9fG6Z2h8SJ15VxXlmD1SY4fuXnbS8n6Z6MfxFWjunbLVRsvL.jpeg","leadcaption":"Lead ","followupcaption":""},{"name":"TechAviv Founder Partners","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/techaviv-founder-partners","logokey":"$Mx6QVN5G8Qj70kWIa3WEK9vVM9NyI81zfXemCnDtIIr1b0qcKyWCfk.png","tagline":null,"urlname":"/investor_page/techaviv-founder-partners","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4Ivz1LULDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"6IyZv5s1y04dm9aDJITFZAXTHxWS0nQhrNohJf0xHW5ymoKu84m3zY","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$Mx6QVN5G8Qj70kWIa3WEK9vVM9NyI81zfXemCnDtIIr1b0qcKyWCfk.png","leadcaption":"","followupcaption":""},{"name":"Samsung Next TLV","type":"Investor","amount":null,"hidden":false,"country":"United States","fullurl":"/investor_page/samsung-next-tlv","logokey":"$oPD5FTb5fGsUqtq4RH2XKfkNNIWs4LZyPZQsOaIF77uo9mM07tylAX","tagline":null,"urlname":"/investor_page/samsung-next-tlv","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwOPhwoYLDA","fundingtype":"Corporate VC","leadpartner":null,"investmentid":"VIGSO7igNTxhC5wWS3SQgcF5yJG8vhVVOBZUUIhMJ3yGIrM00mPtMP","fundingsubtype":"Corporate VC","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$oPD5FTb5fGsUqtq4RH2XKfkNNIWs4LZyPZQsOaIF77uo9mM07tylAX","leadcaption":"","followupcaption":""},{"name":"Supernode Ventures","type":"Investor","amount":null,"hidden":false,"country":"United States","fullurl":"/investor_page/supernode-ventures","logokey":"$TikyZFaSEWjssSKz3G9FgHUUujIuKMv94GuoAOFL63FEqEmAJkA97b","tagline":"Venture capital firm","urlname":"/investor_page/supernode-ventures","isisraeli":0,"investorid":"wxU2CcA7ODmhVs3mzuGgHbJEkouFAal8yYJQU8oGr8MwWLxj4x1uZx","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"hZOoNlEIdFC0V5IBHr7cwUiEJdP07ZxqBuqpHZGqoJFY6DChqZOHX3","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$TikyZFaSEWjssSKz3G9FgHUUujIuKMv94GuoAOFL63FEqEmAJkA97b","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Seed","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":5000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"nonequityfunding":[],"merger_acquisitions":[],"others":[]}}